MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Long Term Provisions | ₹13 Cr | ₹1.86 Cr | ₹2.11 Cr | ₹1.48 Cr | ₹1.36 Cr |
What is the latest Long Term Provisions ratio of MARKSANS PHARMA ?
Year | Long Term Provisions |
---|---|
Mar2023 | ₹13 Cr |
Mar2022 | ₹1.86 Cr |
Mar2021 | ₹2.11 Cr |
Mar2020 | ₹1.48 Cr |
Mar2019 | ₹1.36 Cr |
How is Long Term Provisions of MARKSANS PHARMA Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2023 | ₹13 Cr | 586.21 | |
Mar2022 | ₹1.86 Cr | -12.08 | |
Mar2021 | ₹2.11 Cr | 43.12 | |
Mar2020 | ₹1.48 Cr | 8.78 | |
Mar2019 | ₹1.36 Cr | - |
Compare Long Term Provisions of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹7,634.2 Cr | 1% | 0.4% | 137.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹356,673.0 Cr | -2.9% | 0% | 59.6% | Stock Analytics | |
CIPLA | ₹119,930.0 Cr | 5.8% | 6.2% | 60.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹109,446.0 Cr | 5% | 8% | 25.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹108,261.0 Cr | -2.6% | 15.3% | 114.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,830.6 Cr | 0.9% | -1.5% | 32.2% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | 1% |
0.4% |
137.6% |
SENSEX | 2% |
2.3% |
22.2% |
You may also like the below Video Courses